High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial
Ferreri, Andrés JM, Dr, Reni, Michele, MD, Foppoli, Marco, MD, Martelli, Maurizio, MD, Pangalis, Gerasimus A, MD, Frezzato, Maurizio, MD, Cabras, Maria Giuseppina, MD, Fabbri, Alberto, MD, Corazzelli, Gaetano, MD, Ilariucci, Fiorella, MD, Rossi, Giuseppe, MD, Soffietti, Riccardo, MD, Stelitano, Caterina, MD, Vallisa, Daniele, MD, Zaja, Francesco, MD, Zoppegno, Lucía, MD, Aondio, Gian Marco, MD, Avvisati, Giuseppe, MD, Balzarotti, Monica, MD, Brandes, Alba A, MD, Fajardo, José, MD, Gomez, Henry, MD, Guarini, Attilio, MD, Pinotti, Graziella, MD, Rigacci, Luigi, MD, Uhlmann, Catrina, MD, Picozzi, Piero, MD, Vezzulli, Paolo, MD, Ponzoni, Maurilio, MD, Zucca, Emanuele, MD, Caligaris-Cappio, Federico, MD, Cavalli, Franco, MD
Published in The Lancet (British edition) (31.10.2009)
Published in The Lancet (British edition) (31.10.2009)
Get full text
Journal Article